Navigation Links
PharmAthene to Present at The Maxim Group Growth Conference September 29, 2009
Date:9/23/2009

ANNAPOLIS, Md., Sept. 23 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that management will present at the Maxim Group Growth Conference 2009. The Company is scheduled to present on Tuesday, September 29(th) 2009 at 11:00 a.m. E.T. in the Imperial Room at the Grant Hyatt Hotel, New York City.

PharmAthene's presentation will be webcast live and will be archived for 90 days. The webcast can be accessed at: http://www.wsw.com/webcast/maxim2/pip/

About PharmAthene, Inc.

PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead product development programs include:

  • SparVax(TM) -- a second generation recombinant protective antigen (rPA) anthrax vaccine
  • Third generation rPA anthrax vaccine
  • Valortim((R))-- a fully human monoclonal antibody for the prevention and treatment of anthrax infection
  • Protexia((R)) -- a novel bioscavenger for the prevention and treatment of morbidity and mortality associated with exposure to chemical nerve agents
  • RypVax(TM) -- a recombinant dual antigen vaccine for plague

For more information about PharmAthene, please visit www.PharmAthene.com.


'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. PharmAthene to Present at the Rodman and Renshaw/Acumen BioFin 9th Annual Healthcare Conference
2. PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM)
3. PharmAthene Reports Year End 2008 Financial Results
4. PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants
5. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
6. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
7. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
8. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
9. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
10. AtriCure to Present at Roth Capital Partners 2007 New York Conference
11. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... Dr. David Mahon leads ... NV 89052. Dr. Mahon was named a 2017 Top Patient Rated Henderson Dentist ... an online directory that recognizes local physicians and dentists who have earned high ratings ...
(Date:2/23/2017)... ... February 23, 2017 , ... Current Meditation , a ... franchising throughout the U.S. starting this spring. Current Meditation focuses on “meditation for ... mainstream. Current Meditation will be the first meditation concept in the U.S. offering ...
(Date:2/23/2017)... ... (PRWEB) February 23, ... the nation to come together to combine its favorite springtime ... its favorite fruit – apples! To celebrate National Nutrition Month, ... the “Apple Madness” bracket tournament – a five-week, five-round online ...
(Date:2/23/2017)... ... 23, 2017 , ... Curemark, LLC announced today that the Blüm Study, a ... aged 3-8 with Autism, is now enrolling at three new sites. These new sites ... States. , “There are currently no approved drugs that address the core symptoms ...
(Date:2/23/2017)... ... February 23, 2017 , ... Carlos Gutierrez ... has also continued to spiritually evolve, which is the purpose of everyone in this ... Spiritual Truths ” (published by Balboa Press) attempts to guide readers to expand one’s ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... February 23, 2017 On Wednesday, February ... as four out of nine sectors finished the trading sessions ... a flat closing. Major US indices were also mixed at ... day at 5,860.63, slightly down by 0.09%; the Dow Jones ... the S&P 500 closed at 2,362.82, down 0.11%. This Thursday ...
(Date:2/23/2017)... 23, 2017   SeraCare Life Sciences , ... vitro diagnostics manufacturers and clinical laboratories, is announcing ... of NGS-Based Tests" to be hosted by ... 11am Eastern Standard Time (US). The ... need for improved performance and global standardization in ...
(Date:2/23/2017)... February 23, 2017 ML Capital Group, Inc. ... Colorado Highlife Tours , a Colorado ... partnership with Puration, Inc. (USOTC: PURA) to enter Colorado,s ... product. The Colorado Highlife Tours acquisition announced today is intended to ... ...
Breaking Medicine Technology: